Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.81
+0.07 (0.55%)
Feb 4, 2026, 1:35 PM CST

SHE:301211 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Net Income
37.8291.55176.12125.79121.65168.07
Depreciation & Amortization
25.4325.4321.6621.7619.3718.19
Other Amortization
0.290.290.1---
Loss (Gain) From Sale of Assets
---0.18-0.040.070.03
Asset Writedown & Restructuring Costs
0.110.112.580.6600.35
Loss (Gain) From Sale of Investments
-19.03-19.03-4.02--10.7-5.59
Provision & Write-off of Bad Debts
0.070.07-0.6-1.721.020.43
Other Operating Activities
21.88-1.76-3.5-4.594.424.99
Change in Accounts Receivable
1.271.2749.3131.65-61.5313.51
Change in Inventory
35.9535.95-59.1-25.2145.09-60.49
Change in Accounts Payable
-39.44-39.44-46.29100.93.92-17.73
Operating Cash Flow
65.9896.07137.06250.79123.98121.67
Operating Cash Flow Growth
-35.96%-29.91%-45.35%102.28%1.90%-67.32%
Capital Expenditures
-87.6-164.43-186.53-75.95-21.07-13.39
Sale of Property, Plant & Equipment
0.070.090.470.060.010.06
Investment in Securities
102.03-949.58-21.4-103.9824057.68
Other Investing Activities
7.994.45--10.7-
Investing Cash Flow
22.5-1,109-207.47-179.86229.6544.35
Long-Term Debt Issued
-----60
Long-Term Debt Repaid
----1.33--80
Net Debt Issued (Repaid)
----1.33--20
Issuance of Common Stock
----1,416-
Common Dividends Paid
-72-138.24-96-72--
Other Financing Activities
-2.45-1.63-1.17-4.06-11.02-103.37
Financing Cash Flow
-74.45-139.87-97.17-77.391,405-123.37
Foreign Exchange Rate Adjustments
1.042.073.814.93-4.42-2.76
Net Cash Flow
15.08-1,151-163.76-1.531,75439.89
Free Cash Flow
-21.61-68.36-49.47174.84102.92108.28
Free Cash Flow Growth
---69.89%-4.96%-68.15%
Free Cash Flow Margin
-5.02%-15.33%-7.46%33.96%19.04%18.26%
Free Cash Flow Per Share
-0.05-0.17-0.120.420.330.34
Cash Interest Paid
-----2.28
Cash Income Tax Paid
8.418.7932.928.7332.429.73
Levered Free Cash Flow
-15.2-93.94-118.8102.264.84-39.97
Unlevered Free Cash Flow
-15.04-93.75-118.61102.4264.84-38.54
Change in Working Capital
-0.59-0.59-55.1108.93-11.85-64.8
Source: S&P Global Market Intelligence. Standard template. Financial Sources.